T-Cell Responses to Neoantigens Post Treatment With Ipilimumab in Men With Metastatic Castration-Resistant Prostate Cancer
Clinical trial NCT02113657 · COMPLETED
Trial details
- NCT number
- NCT02113657
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-20
- Primary completion
- 2019-11-04
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.